by Wellcome Trust Sanger Institute Credit: Unsplash/CC0 Public Domain Targeting a specific cancer survival gene in colorectal cancer could lead to new treatment options for advanced disease, new research suggests. Researchers from the Wellcome Sanger Institute, in collaboration with the Candiolo Cancer Institute in Italy and the Netherlands Cancer Institute, used state-of-the-art patient derived organoid models to gather information about this...
